Jiemiao Hu

The University of Texas MD Anderson Cancer Center — United States

Medicine · Health Sciences

16h-index5.3kcitations72works3.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

CAR-T cell therapy research(29), Immune Cell Function and Interaction(25), Cancer Immunotherapy and Biomarkers(23), Immunotherapy and Immune Responses(17), Virus-based gene therapy research(12)

Publications72 total

Designing immune-evasive ucar-T cells to overcome allogeneic barriers and advance off-the-shelf immunotherapy
Blood·2025Open Access
Adoptive transfer of membrane-anchored and tumor cell surface vimentin-targeted interleukin 12 armed TILs suppresses collagen expression to boost deep T-cell tumor infiltration 2033
The Journal of Immunology·2025Open Access
Collagen-disrupting attIL12 TIL therapy boosts deep T cell infiltration via dual signaling activation and CCKAR reduction in sarcomas
Proceedings of the National Academy of Sciences·2025Open Access
Toward human-scale magnetic particle imaging: Technical challenges and clinical prospects
Magnetic Medicine·2025· 1 citedOpen Access
SIX1 transmits signals for breast cancer progression via the ZEB1/IL6/STAT3 signaling axis
Oncogene·2025Open Access
FLASH radiotherapy: mechanisms, nanotherapeutic strategy and future development
Nanoscale Advances·2024· 5 citedOpen Access
A first-in-human phase 1 trial of T cell membrane-anchored tumor targeted IL12 (ATTIL12) -T cell therapy in advanced/metastatic soft tissue and bone sarcoma.
Journal of Clinical Oncology·2024· 2 cited
ATTIL12-T CELL THERAPY FOR SIMULTANEOUSLY DISRUPTING STROMA/TUMORS AND INDUCTION OF ENDOGENOUS TCR-T CELLS
Cytotherapy·2024
Abstract 1083: Cell membrane-anchored and tumor-targeted IL12 T-cell therapy destroys cancer-associated fibroblasts and disrupts extracellular matrix in heterogenous osteosarcoma xenograft models
Cancer Research·2024
Cell membrane-anchored and tumor-targeted IL-12 T-cell therapy destroys cancer-associated fibroblasts and disrupts extracellular matrix in heterogenous osteosarcoma xenograft models
Journal for ImmunoTherapy of Cancer·2024· 27 citedOpen Access
Abstract 4102: attIL12-T cell therapy destructs cancer-associated fibroblasts and extracellular matrix in heterogenous osteosarcoma xenograft models
Cancer Research·2023· 1 cited
Data from Induction of NKG2D Ligands on Solid Tumors Requires Tumor-Specific CD8<sup>+</sup> T Cells and Histone Acetyltransferases
2023Open Access
Supplementary Figures 1 through 9 and Supplementary Materials and Methods from Induction of NKG2D Ligands on Solid Tumors Requires Tumor-Specific CD8<sup>+</sup> T Cells and Histone Acetyltransferases
2023Open Access
Supplementary Figures 1 through 9 and Supplementary Materials and Methods from Induction of NKG2D Ligands on Solid Tumors Requires Tumor-Specific CD8<sup>+</sup> T Cells and Histone Acetyltransferases
2023Open Access
Data from Induction of NKG2D Ligands on Solid Tumors Requires Tumor-Specific CD8<sup>+</sup> T Cells and Histone Acetyltransferases
2023Open Access
Data from T-cell Homing Therapy for Reducing Regulatory T Cells and Preserving Effector T-cell Function in Large Solid Tumors
2023Open Access
Data from Membrane-Anchored and Tumor-Targeted IL12 (attIL12)-PBMC Therapy for Osteosarcoma
2023Open Access
Supplementary Figure from Membrane-Anchored and Tumor-Targeted IL12 (attIL12)-PBMC Therapy for Osteosarcoma
2023Open Access
Data from Membrane-Anchored and Tumor-Targeted IL12 (attIL12)-PBMC Therapy for Osteosarcoma
2023Open Access
Supplementary Figure from Membrane-Anchored and Tumor-Targeted IL12 (attIL12)-PBMC Therapy for Osteosarcoma
2023Open Access
page 1 of 4Next →

Frequent Co-authors

Shulin Li(40), Xueqing Xia(31), Richard Görlick(14), Wendong Zhang(10), Jun Yan(8), Kris M. Mahadeo(8), Qingnan Zhao(7), Patrick Hwu(6), Chantale Bernatchez(6), Gianpietro Dotti(6), Zhiliang Jia(5), Amy B. Heimberger(5), Long Dao(5), Abhisek Mitra(5), Alexander J. Lazar(4), Jian Wang(4), Natalie W. Fowlkes(4), Qing Yang(4), Liangfang Zhang(4), Eugenie S. Kleinerman(4)